Main Article Content
hidradenitis suppurativa, HS, Acne Inversa, Coronavirus, COVID-19, Telehealth, Teledermatology
Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory condition that requires frequent dermatology visits. Coronavirus disease (COVID-19) led to a shift in healthcare delivery to telemedicine. Teledermatology can be valuable for HS patients to decrease travel and wait times and improve patient access. However, we hypothesized that people with HS may have concerns or challenges participating in HS due to its frequent occurrence in sensitive or difficult-to-photograph locations.
Methods: A cross-sectional survey was sent to patients with HS at one academic institution as well as leaders of three patient networks.
Results: Survey responses were received from 149 patients. A total of 94.4% were willing to have an online appointment due to COVID-19, and 88.9% were willing to use teledermatology if COVID-19 had not happened. 32.3% of patients reported that they had ever missed an appointment not due to COVID-19.
Discussion: Our findings support patient willingness to use teledermatology for treatment and management of their HS.
2. Latifi R, Doarn CR. Perspective on COVID-19: Finally, Telemedicine at Center Stage. Telemed J E Health. 2020.
3. Shah M, Naik HB, Alhusayen R. Hidradenitis suppurativa: the importance of virtual outpatient care during COVID-19 pandemic. J Am Acad Dermatol. 2020.
4. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381.
5. Lamel S, Chambers CJ, Ratnarathorn M, Armstrong AW. Impact of Live Interactive Teledermatology on Diagnosis, Disease Management, and Clinical Outcomes. Arch Dermatol. 2012;148(1):61–65.
6. Wicklund, E., 2020. Experts Weigh In On Post-COVID-19 Telehealth Rules And Policies. [online] mHealthIntelligence. Available at: